Nebraska Hematology Oncology

What Nebraska Hematology Oncology does

Nebraska Hematology Oncology (NHO) is an independent, physician-led medical practice founded in 1997 and headquartered in Lincoln, Nebraska, providing comprehensive hematology and oncology care to patients diagnosed with cancer and blood disorders. The practice operates three Lincoln-area facilities: a Cancer Center at 4004 Pioneer Woods Drive, a Support Center at 4001 Pioneer Woods Drive, and a Radiation Oncology facility at 8001 Eiger Drive, and is staffed by five physicians (Eric J. Avery MD, Madhu V. Midathada MD, Kailash Mosalpuria MD MPH FACP, Amanda M. Woodward MD, Kevin Yiee MD) plus additional advanced practice clinicians and 51-100 total employees. Service lines span medical oncology (chemotherapy, immunotherapy, targeted therapy, hormone therapy), hematology, radiation oncology using an Elekta LINAC enhanced with Aktina SRS Cones for stereotactic radiosurgery, genetic counseling, palliative medicine, behavioral health, survivorship programs, child life services, and an in-house NHO Pharmacy. Care is coordinated through an Oncology Medical Home model, and clinical-trial access is delivered through the wholly owned NHO Revive subsidiary.

NHO generates revenue primarily through standard medical billing to patients and insurance providers for clinical services, supplemented by clinical-trial research participation through NHO Revive and in-house pharmacy dispensing. The practice is the only Nebraska site selected for the global INTerpath-011 Phase 2 bladder cancer trial and the INTerpath-002 Phase 3 lung cancer trial, providing a differentiated clinical-trial access point in a region typically served by community oncology rather than large academic centers. Patient acquisition relies on physician referrals, self-referrals, community outreach, and a direct-to-patient digital presence including the yourcancercare.com website, Facebook, Instagram, and email newsletter. The practice maintains QOPI (2011-2026), ASCO, and ACHC certifications and is a member of the Community Oncology Alliance and OneHealth Nebraska. NHO is privately held by its practicing physicians with no disclosed parent company, private equity backing, or institutional investors, and has not pursued acquisitions, funding rounds, or geographic expansion beyond the Lincoln market.

Name

Nebraska Hematology Oncology

Legal name

Nebraska Hematology Oncology

Website

https://yourcancercare.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

51–100 employees

Short description

Nebraska Hematology Oncology is an independent physician-led medical practice in Lincoln, Nebraska providing comprehensive cancer and blood-disorder care including medical oncology, radiation oncology, clinical trials, and supportive services to patients across the region.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Care Services

NAICS

Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Medical oncology services
• Hematology treatment
• Radiation oncology
• Oncology clinical trials
• Cancer care center

Headquarters

HQ city

Lincoln

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Patient Care Services: Revenue generated from medical oncology, hematology, and radiation oncology services billed to patients and insurance providers. Services include chemotherapy, immunotherapy, targeted therapy, and radiation therapy treatments.
2. Clinical Trial Research: Revenue generated through participation in clinical trials, potentially including research stipends and pharmaceutical company partnerships for Phase 2 and Phase 3 oncology trials.
3. In-house Pharmacy Services: NHO Pharmacy provides in-house medication dispensing, generating revenue from prescription medications for cancer treatment and supportive care.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Nebraska Hematology Oncology (NHO) is an independent medical practice in Lincoln, Nebraska that provides comprehensive cancer and blood disorder care, including medical oncology (chemotherapy, immunotherapy, targeted therapy), radiation oncology, hematology services, clinical trials via its NHO Revive division, an in-house pharmacy, genetic counseling, and supportive care such as behavioral health, palliative medicine, and survivorship programs. The practice operates three Lincoln-based facilities (Cancer Center, Support Center, and Radiation Oncology) and serves patients from Lincoln and the broader Nebraska region.

Product overview

Nebraska Hematology Oncology (NHO) is an independent medical practice offering comprehensive cancer care and blood disorder treatment. The practice operates a multi-modality care model consisting of the Cancer Center (medical oncology with chemotherapy, immunotherapy, and targeted therapy), Radiation Oncology (using Elekta LINAC with Aktina SRS Cones for stereotactic radiosurgery), NHO Revive (clinical research division offering Phase 2/3 trials), NHO Support Center (behavioral health, palliative medicine, survivorship, child life services, and support groups), and an on-site NHO Pharmacy. Additional services include DigniCap scalp cooling for hair loss prevention and an Oncology Medical Home care coordination model. The practice emphasizes personalized, compassionate care with a team of five physicians and serves patients in the Lincoln, Nebraska area.

Differentiator

Problem solved

Functional benefit

Brands

• NHO Revive: Clinical research division of Nebraska Hematology-Oncology focused on conducting clinical trials for cancer treatments.

Products and services

• NHO Cancer Center (Medical Oncology) The primary medical oncology facility offering personalized treatment plans for cancer and blood disorders, providing chemotherapy, immunotherapy, targeted therapy, and coordinated cancer care delivered by a team of hematology and oncology specialists. Targeted at patients diagnosed with various cancer types and hematologic conditions in Lincoln and surrounding Nebraska communities.
• Radiation Oncology Advanced radiation therapy services delivered from a dedicated Lincoln facility using Elekta LINAC technology enhanced with the Aktina SRS Cones system to provide precise stereotactic radiosurgery for cancer patients.
• NHO Revive Clinical Research Clinical trials division providing access to cutting-edge Phase 2 and Phase 3 oncology studies. NHO Revive is the only clinical research site in Nebraska participating in global trials including INTerpath-011 (bladder cancer) and INTerpath-002 (lung cancer), enabling Nebraska patients to access investigational therapies without leaving the state.
• NHO Support Center Comprehensive supportive care facility offering behavioral health services, cancer support groups, palliative medicine, survivorship programs, child life services, and genetic counseling for cancer patients and their families.
• NHO Pharmacy On-site pharmacy providing convenient access to oral and infused medications for patients undergoing cancer treatment, with weekday operating hours (Monday-Thursday 8:30am-4:30pm, Friday 8:30am-2:30pm).
• DigniCap Scalp Cooling FDA-cleared scalp cooling system designed to reduce the likelihood of chemotherapy-induced hair loss for patients undergoing cancer treatment at NHO.
• Genetic Counseling Hereditary cancer risk assessment and genetic testing services that help patients understand their cancer risk and make informed decisions about prevention and early detection.

Quantifiable outcome

• NHO Revive is the only clinical research site in Nebraska participating in Phase 2 bladder cancer trial and Phase 3 lung cancer trial

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• INTerpath-011 Clinical Trial ConsortiumcoreStrategic or Co-development Partner · 4 June 2026NHO Revive is the only clinical research site in Nebraska selected to participate in the INTerpath-011 Phase 2 study for high-risk bladder cancer, evaluating V940 in combination with BCG.
• INTerpath-002 Clinical Trial ConsortiumcoreStrategic or Co-development Partner · 30 September 2025NHO Revive is the only clinical research site in Nebraska selected to participate in the INTerpath-002 Phase 3 clinical trial for lung cancer evaluating novel therapeutic approaches.
• Quality Oncology Practice Initiative (QOPI)coreStrategic or Co-development PartnerQOPI certification demonstrates the practice's commitment to quality cancer care through adherence to oncology-specific standards and quality measures established by ASCO.
• American Society of Clinical Oncology (ASCO)coreStrategic or Co-development PartnerASCO Certified status recognizes NHO's oncology practice for delivering high-quality, patient-centered cancer care in accordance with ASCO's standards.
• Accreditation Commission for Health Care (ACHC)coreStrategic or Co-development PartnerACHC accreditation validates that NHO meets or exceeds national standards for healthcare quality and safety.
• Community Oncology Alliance (COA)minorStrategic or Co-development PartnerCOA membership connects NHO with community oncology practices for advocacy, education, and sharing of best practices.
• OneHealth NebraskaminorStrategic or Co-development PartnerPartnership in OneHealth Nebraska enables coordination with other healthcare providers in the region for integrated patient care delivery.
• ElektacoreTechnology or IntegrationNHO uses Elekta LINAC (linear accelerator) for radiation therapy treatments. The practice recently enhanced capabilities with Aktina SRS Cones system for stereotactic radiosurgery.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Compass Oncology: Independent community oncology practice in Oregon and Washington offering medical oncology, radiation, clinical trials, and supportive care. Directly comparable multi-modality independent practice model with similar scale and service breadth.
• Northwest Medical Specialties: Independent community hematology/oncology practice offering chemotherapy, immunotherapy, clinical trials, and supportive services. Comparable independent multi-physician community practice model.
• Regional Cancer Care Associates: Large community-based oncology practice operating across the Northeast US. Directly comparable in business model—independent community oncology with medical oncology, hematology, clinical trials, and integrated supportive care—though at significantly larger scale.
• Tennessee Oncology: One of the largest independent community oncology practices in the US, offering medical oncology, radiation, clinical trials, and pharmacy services. Strongly comparable independent-practice model and revenue diversification strategy.
• Florida Cancer Specialists & Research Institute: Large independent community oncology practice with significant clinical trial activity, in-house pharmacy, and integrated supportive care. Highly comparable model to NHO at scale, with similar emphasis on community-based comprehensive cancer care.

Regional players

• Oncology Hematology West: Independent community oncology practice operating in Nebraska, offering medical oncology, hematology, and infusion services. Closest direct comparable in terms of practice size, model, and Nebraska market presence.
• Nebraska Medicine (Fred & Pamela Buffett Cancer Center): The primary academic cancer center in Nebraska, located in Omaha. Directly comparable to NHO as a comprehensive hematology/oncology and radiation therapy provider serving the same Nebraska patient population, but with deeper subspecialty coverage and academic trial portfolio.

Broad incumbents

• City of Hope: National cancer treatment and research organization operating comprehensive cancer centers. Comparable in offering medical oncology, radiation, and clinical trials at a larger scale, serving as a potential academic competitor for complex cases in the region.
• ONE Oncology: Network of independent community oncology practices offering centralized services including clinical trial management, revenue cycle, and technology. Relevant comparable for NHO's independent model and potential partnership trajectory.
• US Oncology Network (McKesson): Nationwide network of independent community oncology practices providing shared services, trial access, and operational support. Comparable to NHO's independent practice model but at network scale with centralized research, technology, and purchasing leverage.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/YourCancerCare
• Instagraminstagram.com/nebraskahematologyoncology
• Xx.com/nehemonc
• LinkedInlinkedin.com/company/nebraska-hematology-oncology

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nebraska Hematology Oncology